Skip to main content

Pfizer Requests Emergency Use Authorization to Administer Vaccine in Children Aged 5-11

Publish date:
Video Rating:
Video Duration:

Pfizer  (PFE) - Get Free Report and BioNTech have officially requested emergency use authorization to administer their COVID-19 vaccine to children aged 5 to 11 from the U.S. Food and Drug Administration.

The company said that its submission is "an important step" as new COVID-19 cases in children are increasing. Nearly 5.9 million children have been infected with COVID-19 since the pandemic started, according to the American Academy of Pediatrics.

Pfizer is the only fully approved FDA vaccine for individuals 16 and over, and is also authorized for emergency use in children aged 12 to 15.

On September 23, the Centers for Disease Control and Prevention endorsed Pfizer’s COVID-19 booster shots for individuals aged 65+ and for vulnerable populations.

Earlier on September 27, U.S. President Biden received Pfizer’s booster shot.

"I know it doesn't look like it, but I am over 65," President Biden, said while receiving the booster shot. "Way over. And that's why I'm getting the booster shot today."

Earlier this week, Johnson & Johnson  (JNJ) - Get Free Report submitted to the FDA for emergency use authorization for its COVID vaccine booster.

Related: Johnson & Johnson Seeks Emergency Use Authorization For Its COVID Booster

Related Videos